INMD: InMode Ltd. - Summary | Jitta

InMode Ltd.

NASDAQ:INMD

Price
$38.39
Loss Chance
42.8%
6.13JITTA SCORE
15.09%Over Jitta Line
Jitta Ranking
42 / 1,197
751 / 5,060
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (69)
Recent Business Performance (53)
Financial Strength (82)
Return to Shareholders (47)
Competitive Advantage (78)
Jitta Signs
Revenue and EarningConsistent High Growth in the past 5 years
Recent Business PerformanceEarning Growth Last Year
Operating MarginConsistent
Debt LevelLow Long Term Debt
Return on EquityConsistently High
CapExVery Low
SG&A to SalesDecreasing Every Year
Recent IPOLess than 3 years
New Share IssuedMore than 50% in 5 years
Key Stats
Jitta Score
Jitta Line
6.13
15.09%
2.00
236.90%
Health Care Equipment
5.45
177.80%
6.90
112.90%
5.24
39.05%
COMPANY DESCRIPTION
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women’s health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.